Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which is Responsive to Losartan Treatment
Year: 2021
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3771098
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4232936722
